Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

AUSTIN, Texas (AP) — Texas Democrats on Monday prevented their state’s House of Representatives from moving forward, at least for now, with a redrawn congressional map sought by President Donald Trump ...

It seems like a fair assessment to state that the many ‘AI’ features that Microsoft added to Windows 11 are at least somewhat controversial. Unsurprisingly, this has led many to wonder about disabling ...

Shares of clinical-stage biotechnology company Recursion Pharmaceuticals (NASDAQ: RXRX) soared 11.43% on Wednesday, significantly outperforming the broader market. The rally followed a major analyst ...

There is perhaps nothing that has plagued the electronics consumer quite as much as bloatware. It’s omnipresent in most modern operating systems and products, whether it’s extra stuff on Android ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Netflix will remove 12 original titles from its library next month. Removals include series, movies, specials, and a musical documentary. Netflix has previously removed high-profile originals, ...

Times Watchdog stories dig deep to hold power accountable, right wrongs and create change. This work is made possible by The Seattle Times Investigative Journalism Fund. Donate today to support ...